You are here: Welcome » Gillian Leng

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
gillian_leng [2022/06/15 05:16]
liam [National University of Singapore (2022-present)]
gillian_leng [2022/06/16 01:42] (current)
liam
Line 13: Line 13:
 ===== Career and Affiliations ===== ===== Career and Affiliations =====
  
-==== National Institute for Health and Care Excellence (2001-present) ====+==== Royal Society of Medicine ==== 
 + 
 +Leng has served as a member of the [[Royal Society of Medicine]] since 1999. She became a trustee in 2013, and was appointed as Honorary Librarian in May 2017, finishing her term in September 2021.((//Professor Gillian Leng announced as RSM Honorary Librarian.// (2017, May 15). The Royal Society of Medicine. https://archive.ph/hZ1ev)) 
 + 
 +==== National Institute for Health and Care Excellence (2001-2021) ====
  
 Leng was on the Board of the [[National Institute for Health and Care Excellence]] (NICE) for over 20 years (2001-2021), most recently as its Chief Executive.  Leng was on the Board of the [[National Institute for Health and Care Excellence]] (NICE) for over 20 years (2001-2021), most recently as its Chief Executive. 
Line 20: Line 24:
  
 Prior to this, Gillian was instrumental in establishing the original clinical guideline programme at NICE, followed by setting up an implementation work programme to ensure the recommendations changed practice. She also developed many of NICE’s new initiatives including indicators for the Quality and Outcomes Framework and for the online portal NICE Evidence.((//About.// International Guideline Credentialing & Certification Program. Retrieved June 9, 2022, from https://archive.ph/XmtCe)) Prior to this, Gillian was instrumental in establishing the original clinical guideline programme at NICE, followed by setting up an implementation work programme to ensure the recommendations changed practice. She also developed many of NICE’s new initiatives including indicators for the Quality and Outcomes Framework and for the online portal NICE Evidence.((//About.// International Guideline Credentialing & Certification Program. Retrieved June 9, 2022, from https://archive.ph/XmtCe))
 +
 +NICE has received funding from the [[Bill & Melinda Gates Foundation]] and [[Rockefeller Foundation]].((//Annual General Meeting and Public Board Meeting.// (2017). NICE. https://web.archive.org/web/20220121060646/https://www.nice.org.uk/Media/Default/Get-involved/Meetings-In-Public/Public-board-meetings/agenda-and-papers-jul-17.pdf))
  
 ==== King's College London (2012-present) ==== ==== King's College London (2012-present) ====
  
-Leng is a visiting professor at [[King's College London]].+Leng is a visiting professor at [[King's College London]].((//Gillian Leng, MD.// World Neuroscience Innovation Forum. Retrieved June 14, 2022, from https://archive.ph/ubOne)) 
 + 
 +==== International Festival of Public Health (2015) ==== 
 + 
 +Leng participated as a keynote speaker at the 2015 [[International Festival of Public Health]].((//Professor Gillian Leng CBE (The University of Manchester).// International Festival of Public Health. Retrieved June 15, 2022, from https://archive.ph/njo0r)) ((//International Festival of Public Health UK 2015.// (2015). International Festival of Public Health. https://web.archive.org/web/20220615153143/http://www.festivalofpublichealth.co.uk/media/mhs/festivalofpublichealth/Festival-Programme-2015-FINAL-FULL.pdf)) 
 + 
 +==== World Neuroscience Innovation Forum (2017) ==== 
 + 
 +Leng was a speaker at the [[World Neuroscience Innovation Forum]] in 2017, where she discussed gene and cell therapy in treating neurological diseases.((//Gillian Leng, MD.// World Neuroscience Innovation Forum. Retrieved June 14, 2022, from https://archive.ph/ubOne)) 
 + 
 +==== International Society for Pharmacoeconomics and Outcomes Research (2018) ==== 
 + 
 +Leng participated as a speaker at the [[International Society for Pharmacoeconomics and Outcomes Research|ISPOR Summit 2018]].((//Gillian Leng, CBE.// (2022). ISPOR | International Society for Pharmacoeconomics and Outcomes Research. https://archive.ph/V8kem)) 
 +==== Cochrane ==== 
 + 
 +Leng was formerly an editor for [[Cochrane]].((Toolan, M., & Maisuria, R. (2021). //Ten minutes with Professor Gillian Leng, Chief Executive, National Institute for Health and Care Excellence.// BMJ Leader, leader-2021-000472. https://doi.org/10.1136/leader-2021-000472))
  
 ==== Guidelines International Network (2018-present) ==== ==== Guidelines International Network (2018-present) ====
  
 Leng is a trustee of the [[Guidelines International Network]]. Leng is a trustee of the [[Guidelines International Network]].
 +
 +==== European Society of Cardiology (2019) ====
 +
 +Leng delivered a presentation for the [[European Society of Cardiology]] at Digital Health 2019.((//A NICE perspective on real world evidence. Session at Digital Health 2019.// ESC 365. Retrieved June 15, 2022, from https://archive.ph/NjorQ)) The ESC 365 platform is sponsored by [[pharmaceutical_companies:Novo Nordisk]].
 +
 +==== GIANT Health (2020) ====
 +
 +Leng was scheduled as a speaker at the 2020 [[GIANT Health]] conference.((//Gillian Leng.// GIANT Health. Retrieved June 15, 2022, from https://archive.ph/3GT0J))
 +
 +==== Westminster Health Forum (2020) ====
 +
 +Leng was a speaker at a 2020 seminar called //The future for NICE in health and social care//,
 +hosted by the [[Westminster Health Forum]].((//The future for NICE in health and social care.// (2022). Westminster Health Forum. https://archive.ph/70o8O))
  
 ==== Global Commission on Evidence to Address Societal Challenges ==== ==== Global Commission on Evidence to Address Societal Challenges ====
Back to top